Global Retirement Partners’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76K Buy
+330
New +$3.01K ﹤0.01% 3896
2025
Q4
$3.21K Hold
176
﹤0.01% 3575
2025
Q3
$2.58K Sell
176
-473
-73% -$8.11K ﹤0.01% 3229
2025
Q2
$11.8K Buy
+649
New +$13.2K ﹤0.01% 2532
2024
Q4
$3.02K Hold
176
﹤0.01% 2916
2024
Q3
$3.52K Buy
+176
New +$2.74K ﹤0.01% 2718

Other funds holding ADMA

Global Retirement Partners's ADMA Position: Q2 2026 in Review

Global Retirement Partners opened a new position in ADMA Biologics (ADMA) in Q2 2026: 330 shares worth $2.76K. The stake represents ﹤0.01% of the portfolio and ranks #3896 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in ADMA as recently as Q4 2025.

Global Retirement Partners first reported a position in ADMA in Q3 2024 and has held it in 6 quarters since. The position peaked at $11.8K in Q2 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Global Retirement Partners held 330 shares of ADMA Biologics worth $2.76K as of Q2 2026.
  • ADMA Biologics was a new Global Retirement Partners position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3896 holding.
  • Global Retirement Partners first reported a position in ADMA Biologics in Q3 2024 and has held it in 6 quarters since.
  • Global Retirement Partners's ADMA Biologics position peaked at $11.8K in Q2 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.